Cost-Effectiveness Research in Neurosurgery: We Can and We Must.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29315414.
- Also identified by DOI 10.1093/neuros/nyx583.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rapid advancement of medical and surgical therapies, coupled with the recent preoccupation with limiting healthcare costs, makes a collision of the 2 objectives imminent. This article explains the value of cost-effectiveness analysis (CEA) in reconciling the 2 competing goals, and provides a brief introduction to evidence-based CEA techniques. The historical role of CEA in determining whether new neurosurgical strategies provide value for cost is summarized briefly, as are the limitations of the technique. Finally, the unique ability of the neurosurgical community to provide input to the CEA process is emphasized, as are the potential risks of leaving these important decisions in the hands of others.
Medical subject headings
- Cost-Benefit Analysis
- Evidence-Based Medicine
- Neurosurgery
- Neurosurgical Procedures